Skip to content

A Study to Validate a Pain Diary for Patient With Trigeminal Neuralgia

A Study to Validate a Diary Developed by Noema Pharma That Will be Used for Future Trigeminal Neuralgia Clinical Research Studies to Capture Pain Dimensions.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06019338
Enrollment
30
Registered
2023-08-31
Start date
2021-11-20
Completion date
2023-08-31
Last updated
2024-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Trigeminal Neuralgia

Brief summary

The aim of the study is to establish the validity of a patient reported diary in TN . The following objectives have been identified: 1. To generate evidence to support diary content validity by performing qualitative research studies with TN patients and Healthcare Professionals (HCPs). 2. To provide further support to the diary, sensitivity to change, known groups validity (ability to differentiate between severity groups), and construct validity.

Detailed description

This study will engage up to 20 participants with TN through patient associations or HCPs. The study will be conducted in English Speaking countries. The study comprises the following parts : * Participants Recruitment * Completion of the Diary * Qualitative interviews with participants * Analysis of qualitative research to assess content validity * Secondary analysis as a workshop with a panel of experts to finalize the diary The diary will be provided to each participant and to HCPs. Participants will be requested to follow the instructions, use the diary and provide their feedback on the diary.

Interventions

OTHERPain Diary use

Validation of a pain diary specifically designed to capture pain dimensions of Trigeminal Neuralgia

Sponsors

Noema Pharma AG
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum

Inclusion criteria

* Male or Female aged of 40 years or more. * Must be able to read, write, and speak English to complete the consent process and participate in an interview. * Able and willing to provide consent for participation in the study, and to allow the study team to access their data entries including audio or video recordings. - - Participant with a current or previous diagnosis of TN * Willing to participate in up to 30 minutes remote interviews or in-person interview (this interview will be recorded by the HCP) * Committ to fill in the diary according to the HCP instruction

Exclusion criteria

* Not applicable

Design outcomes

Primary

MeasureTime frameDescription
Measure of pain associated with Trigeminal Neuralgia2 weeksUse of the TN Pain questionnaire to measure the pain associated with trigeminal neuralgia
Concept elicitation of the diary content1 dayDuring an interview, assess if the questionnaire is comprehensive, clear and correctly captures patients experience

Countries

United Kingdom, United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 14, 2026